- Published at
- by themarketherald.com.au
mixed
mixed
Friday’s HotCopper Trends: Orthocell ramps up, Australian Vanadium advances project | May 8, 2025
The ASX200 has been up 0.45% at around 8,230 points. Orthocell (ASX:OCC)…
News for Orthocell Limited (OCC.AX)
- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Index continues winning streak | April 30, 2025
The ASX200 closed up 0.69% at 8,126 points. IT was the best…- Published at
- by themarketherald.com.au
mixedmixed- Published at
- by smallcaps.com.au
positivepositiveOrthocell appoints first four distributors for Remplir nerve repair technology in the US
Regenerative medicine company Orthocell (ASX: OCC) has appointed the first four US distributors for the company’s flagship nerve repair product Remplir.- Published at
- by themarketherald.com.au
positivepositiveASX Market Close: Local bourse back to 7,800pts ahead of Easter long weekend
The ASX went its own way despite Wall Street’s overnight finish to close out this shortened trading week, climbing back above the 7,800 points level.- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Tariff pause bounceback lifts animal spirits, but certainty elusive
Good Afternoon and welcome to HotCopper’s Market Close for Thursday 10th of April,…- Published at
- by themarketherald.com.au
mixedmixedFriday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025
The ASX has been down 1.5% at 7,739 points this morning. There’s…- Published at
- by themarketherald.com.au
mixedmixedThursday’s HotCopper Trends: Ramelius’ record, Enova’s drill success | April 3, 2025
The ASX has pared losses and has been down 1.25% at 7,835…- Published at
- by smallcaps.com.au
positivepositiveOrthocell records first sales of Striate+ dental membrane in new European markets
Orthocell (ASX: OCC) has achieved the first sales of its dental guided bone and tissue regeneration product Striate+ into new markets in Germany, Austria- Published at
- by themarketherald.com.au
positivepositiveASX Market Close: Index pares gains, Gold hits new record | March18, 2025
The ASX200 pared early gains to close up by a sliver of…- Published at
- by smallcaps.com.au
positivepositiveOrthocell receives regulatory approval for sales of Striate+ dental membrane into Singapore
Orthocell (ASX: OCC) has received regulatory approval from Singapore’s Health Sciences Authority to commence regional sales of its dental membrane product- Published at
- by themarketherald.com.au
positivepositiveTelix clocks +150% year-on-year returns as radiopharma acquisition well received
Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately.- Published at
- by themarketherald.com.au
positivepositiveClarity jumps as FDA awards fast track status for PET scan imaging agent
Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer…- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: IT stocks lead index higher | January 22, 2025
This was a seven-week closing high, achieved amidst positive sentiment as investors react to Donald Trump’s “Stargate” plan for AI investment.- Published at
- by themarketherald.com.au
positivepositiveASX Market Update: Inflation higher than expected as miners bounce back | January 8, 2025
Inflation edged up more than expected, from 2.1% to 2.3%. More importantly, trimmed mean inflation came in at 3.2%.- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Index dives to three week low | December 12, 2024
Jobs data today surprised analysts, with unemployment falling to 3.9%. Now the odds of an early interest rate cut have lengthened.- Published at
- by themarketherald.com.au
positivepositiveChris Judd’s Talk Ya Book: Orthocell building on ‘enormous potential’ with steady growth – and US push to come
On Chris Judd’s Talk Ya Book today, the AFL legend sat down with Orthocell…- Published at
- by themarketherald.com.au
positivepositiveOrthocell spikes 7% after clearing huge US hurdle for its nerve repair product
The stock’s bull run over the last two months has seen its share price more than double as investors eye the lucrative $1.6B nerve repair market in the US.- Published at
- by themarketherald.com.au
positivepositiveOrthocell raising $17M in placement to fund US launch of Remplir
Orthocell (ASX:OCC) has announced its receipt of commitments for $17M in funding via placement to bankroll the US launch of Remplir.- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Wisetech bounces back as Index takes a breather | October 22, 2024
The local bourse shed some of the gains from recent weeks as investors took profits and re-evaluated their portfolios.